Biolinerx Ltd.

Israel


Create a watch for Biolinerx Ltd.
Total IP 71
Total IP Rank # 19,321
IP Activity Score 2.6/5.0    47
IP Activity Rank # 15,532
Stock Symbol
ISIN IL0011015182
Market Cap. 92.1M  (ILA)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

25 3
7 2
30 4
0
 
Last Patent 2025 - Composition of bl-8040
First Patent 2006 - Novel salts of conjugated psycho...
Last Trademark 2025 - APHEXDA
First Trademark 2022 - APHEXDA

Industry (Nice Classification)

Latest Inventions, Goods, Services

2025 G/S Medicine for mobilization of stem cells.
Invention Composition of bl-8040. A composition comprising BL-8040 (SEQ ID NO: 1) is disclosed herein, whi...
2024 Invention Unit dosage forms and methods comprising bl8040 for intravenous administration. A unit dosage for...
Invention Methods of hematopoietic precursor cells mobilization. A method of mobilizing hematopoietic precu...
2023 Invention Composition of bl-8040. A composition comprising BL-8040 (SEQ ID NO: 1) is disclosed herein, whic...
Invention Treatment of sickle cell disease. A method of mobilizing CD34+ cells in a subject suffering from ...
G/S Pharmaceutical product development services, namely, pharmaceutical product development through t...
G/S Pharmaceutical development services, namely pharmaceutical development through the discovery of ...
2022 G/S Medicine for mobilization of stem cells
G/S Medicine for mobilization of stem cells.
2021 Invention Process for manufacturing peptide. (vii) substitution of the resin is at least 0.3 milliequivalen...
Invention Process for manufacturing peptide. A large-scale process is described herein for preparing a cycl...
Invention Cxcr4 inhibitor for the treatment of acute respiratory distress syndrome and viral infections. A...
Invention Cxcr4 inhibitor for the treatment of acute respiratory distress syndrome and viral infections. A ...
2020 Invention Compositions, articles of manufacture and methods for treating cancer. A method of treating canc...
Invention Combination therapy for the treatment of cancer. A method of treating a solid tumor in a subject ...
Invention Compositions and methods for treating cancer. Use of a CXCR4 antagonistic peptide and an immune-c...
Invention Compositions and methods for treating cancer. Use of a CXCR4 antagonistic peptide and an immune-...
2019 Invention Specific combination therapy for treatment of pancreatic cancer. A method of treating metastatic...
Invention Specific combination therapy for treatment of pancreatic cancer. A method of treating metastatic ...
Invention Combination therapy for treatment of pancreatic cancer. A method of treating metastatic pancreati...
Invention Treatment of metastatic pancreatic adenocarcinoma. A method of treating metastatic pancreatic ade...
Invention Methods of selecting treatment for cxcr4-associated cancer. A method of selecting a treatment re...
Invention Methods of selecting treatment for cxcr4-associated cancer. A method of selecting a treatment reg...
Invention Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors. A method of trea...
Invention Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors. A method of treat...
2018 Invention Methods of treating acute myeloid leukemia with a flt3 mutation. There is provided a method of t...
Invention Methods of treating diseases associated with vascular smooth muscle cell proliferation. A method...
Invention Methods of treating diseases associated with vascular smooth muscle cell proliferation. A method ...
Invention Methods of treating myeloid leukemia. There is provided a method of treating a myeloid leukemia....
2016 Invention Cxcr4 binding agents for treatment of diseases. A method of treating cancer in a subject is disc...